GDTC
CytoMed Therapeutics·NASDAQ
--
--(--)
--
--(--)
1.21 / 10
Underperform
The technical framework scores 1.21/10, reflecting challenging technical structure. Strength in no significant factors provides support, but Long Lower Shadow and Long Upper Shadow indicate potential resistance. Overall technical bias leans cautious.
Analysis Checks(0/2)
Long Lower Shadow
Score1.43/10
Win Rate45.28%
Hist. Signals53
Avg Return-1.72%
Score1.43/10
Win Rate45.28%
Hist. Signals53
Avg Return-1.72%
Long Upper Shadow
Score1/10
Win Rate35.85%
Hist. Signals53
Avg Return-0.83%
Score1/10
Win Rate35.85%
Hist. Signals53
Avg Return-0.83%
Long Lower Shadow
Score1.43/10
Win Rate45.28%
Hist. Signals53
Avg Return-1.72%
Score1.43/10
Win Rate45.28%
Hist. Signals53
Avg Return-1.72%
Long Upper Shadow
Score1/10
Win Rate35.85%
Hist. Signals53
Avg Return-0.83%
Score1/10
Win Rate35.85%
Hist. Signals53
Avg Return-0.83%
What is the current technical signals for GDTC?
- GDTC presents a Underperform setup with a Technical Score of 1.21/10. Key technical indicators highlight an RSI of 49.46 and a MACD of 0.05, with the trend anchored by the 50-Day SMA at 1.36. Traders should monitor key support at 0.81 and resistance at 0.87.
